ClinicalTrials.Veeva

Menu

Structural and Functional Networks in ALS: An Insight Into Pseudobulbar Affect

A

Aalborg University Hospital

Status

Enrolling

Conditions

Pseudobulbar Affect
Amyotrophic Lateral Sclerosis

Treatments

Other: Diffusion Kurtosis Imaging (DKI)
Other: Resting State Magnetoencephalography

Study type

Interventional

Funder types

Other

Identifiers

NCT06396260
F2024-014

Details and patient eligibility

About

The investigators aim to elucidate characteristics of structural and functional brain connectivity in patients with amyotrophic lateral sclerosis (ALS) and pseudobulbar affect (PBA) using diffusion kurtosis imaging (DKI) and magnetoencephalography (MEG).

Enrollment

50 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Diagnosed with ALS in the last 6 months according to Gold Coast Criteria

Exclusion criteria

    • Lack of ability to answer survey through own ability or through a surrogate, for example by hand controlled, eye-controlled computer and/or tablet, or through telephone interview.
  • Lack of ability to cooperate.
  • Pregnancy
  • Drug addiction defined as the non-prescribed use of cannabis, opioids, or other narcotics.
  • Alcohol addiction defined as over 21 units weekly.
  • Lesional neurological diseases, such as stroke, tumor or multiple sclerosis
  • Epilepsy
  • Neurodegenerative diseases other than ALS
  • Severe psychiatric disease such as major depression disorder, bipolar disease or schizophrenia
  • Contraindication for MRI and MEG scan according to hospital guidelines
  • Severe liver or kidney disease
  • Dysregulated heart disease
  • Ongoing treatment with any antidepressants or any antipsychotics at recruitment.
  • Diagnosed with frontotemporal dementia.

Trial design

Primary purpose

Other

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

50 participants in 3 patient groups

Control
Active Comparator group
Description:
Sex- and age matched, healthy control. Will only have baseline DKI and MEG performed.
Treatment:
Other: Resting State Magnetoencephalography
Other: Diffusion Kurtosis Imaging (DKI)
ALS without PBA
Active Comparator group
Description:
ALS patient without PBA, either at baseline and 6 month follow-up
Treatment:
Other: Resting State Magnetoencephalography
Other: Diffusion Kurtosis Imaging (DKI)
ALS with PBA
Active Comparator group
Description:
ALS patient with PBA, either at baseline or follow-up
Treatment:
Other: Resting State Magnetoencephalography
Other: Diffusion Kurtosis Imaging (DKI)

Trial contacts and locations

1

Loading...

Central trial contact

Christian Holm Steenkjær; Blicher

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems